Apollo TMS Therapy System
Transcranial Magnetic Stimulator. 510(k) K180313, from Mag & More GmbH (Munich, DE). Product code OBP, class 2.
As of Nov 22, 2026, K180313 is an FDA 510(k) held by Mag & More GmbH, substantially equivalent on May 4, 2018 after 88 days, with no recalls tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The Apollo TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
- NeuroStar TMS Therapy SystemK161519 · Neuronetics, Inc. · Sep 11, 2016
- Rapid2 Therapy SystemK162935 · Magstim Company, Ltd. · Mar 10, 2017
- Apollo TMS Therapy System;Apollo light TMS Therapy SystemK260560 · Mag & More GmbH · May 22, 2026
- Apollo TMS Therapy SystemK243700 · Mag & More GmbH · Sep 4, 2025
- Apollo TMS Therapy SystemK232639 · Mag & More GmbH · May 24, 2024
- KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A)K260396 · Fidelity BioPharma Co. · Sep 6, 2026
- BTL-699K260691 · BTL Industries, Inc. · Aug 23, 2026
- QuickVision Ultimate rTMSK261228 · Brain Ultimate, Inc. · Aug 14, 2026
- MagVenture Accelerated TMS (aTMS) Therapy SystemK260189 · Tonica Elektronik A/S · May 22, 2026
- Apollo TMS Therapy System;Apollo light TMS Therapy SystemK260560 · Mag & More GmbH · May 22, 2026
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)K252358 · Nexstim Oyj · Mar 20, 2026
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)K253098 · Nexstim Oyj · Mar 20, 2026
- SPRY TMS Therapy System (0550)K251653 · Soterix Medical, Inc. · Feb 20, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Abbreviated
- Received
- Feb 5, 2018
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5805
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files